Medicine and Health

Economic Burden of Disease Progression in Multiple Myeloma Patients Receiving Stem Cell Transplant

R. Fonseca, M. Hagiwara, et al.

This research, conducted by Rafael Fonseca, May Hagiwara, Sumeet Panjabi, Emre Yucel, Jacqueline Buchanan, and Thomas Delea, reveals significant insights into healthcare resource utilization and costs for multiple myeloma patients post-stem cell transplant. The findings underscore the financial implications of disease progression, highlighting increased hospitalizations and varying costs across treatment lines.